ANTHEM-HFrEF Pivotal Study

NATerminatedINTERVENTIONAL
Enrollment

533

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Heart FailureHeart Failure, CongestiveHeart Failure, Systolic
Interventions
DEVICE

VITARIA System

Chronic stimulation of the right cervical vagus nerve

Trial Locations (22)

10025

Mount Sinai School St. Luke's, New York

17033

Penn State Health Milton Hershey Medical Center, Hershey

17043

Pinnacle Health, Wormleysburg

32256

First Coast Cardiovascular Institute, Jacksonville

35294

University of Alabama, Birmingham

39216

University of Mississippi Medical Center, Jackson

43606

ProMedica Northwest Ohio Cardiology Consultants, Toledo

44109

MetroHealth System, Cleveland

47303

Indiana University Health Ball Memorial Hospital, Muncie

48197

Michigan Heart, PC, Ypsilanti

53792

University of Wisconsin, Madison

61606

UnityPoint Health - Methodist Hospital, Peoria

72205

Central Arkansas Veterans Healthcare System, Little Rock

75701

Tyler Cardiovascular Consultants, Tyler

77030

Baylor St. Luke's Medical Center, Houston

85724

University of Arizona, Tucson

90073

Greater Los Angeles VA Medical Center, Los Angeles

90806

Long Beach Memorial Hospital, Long Beach

99204

Providence Sacred Heart Medical Center, Spokane

06102

Hartford Hospital, Hartford

02111

Tufts Medical Center, Boston

01805

Lahey Medical Center, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LivaNova

INDUSTRY

NCT03425422 - ANTHEM-HFrEF Pivotal Study | Biotech Hunter | Biotech Hunter